This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danial, N. N.
Right arrow Articles by Rothman, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danial, N. N.
Right arrow Articles by Rothman, P. B.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 1998, p. 6795-6804, Vol. 18, No. 11
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Direct Interaction of Jak1 and v-Abl Is Required for v-Abl-Induced Activation of STATs and Proliferation

Nika N. Danial,1 Julie A. Losman,1 Tianhong Lu,2 Natalie Yip,2 Kartik Krishnan,3 John Krolewski,3 Stephen P. Goff,4,5,6 Jean Y. J. Wang,7 and Paul B. Rothman1,2,4,*

Integrated Program in Molecular, Cellular, and Biophysical Studies,1 Departments of Medicine,2 Microbiology,4 Biochemistry and Molecular Biophysics,5 and Pathology,3 and Howard Hughes Medical Institute,6 Columbia University College of Physicians and Surgeons, New York, New York 10032, and Department of Biology and Center for Molecular Genetics, University of California at San Diego, La Jolla, California 92093-03477

Received 4 February 1998/Returned for modification 30 March 1998/Accepted 23 July 1998

In Abelson murine leukemia virus (A-MuLV)-transformed cells, members of the Janus kinase (Jak) family of non-receptor tyrosine kinases and the signal transducers and activators of transcription (STAT) family of signaling proteins are constitutively activated. In these cells, the v-Abl oncoprotein and the Jak proteins physically associate. To define the molecular mechanism of constitutive Jak-STAT signaling in these cells, the functional significance of the v-Abl-Jak association was examined. Mapping the Jak1 interaction domain in v-Abl demonstrates that amino acids 858 to 1080 within the carboxyl-terminal region of v-Abl bind Jak1 through a direct interaction. A mutant of v-Abl lacking this region exhibits a significant defect in Jak1 binding in vivo, fails to activate Jak1 and STAT proteins, and does not support either the proliferation or the survival of BAF/3 cells in the absence of cytokine. Cells expressing this v-Abl mutant show extended latency and decreased frequency in generating tumors in nude mice. In addition, inducible expression of a kinase-inactive mutant of Jak1 protein inhibits the ability of v-Abl to activate STATs and to induce cytokine-independent proliferation, indicating that an active Jak1 is required for these v-Abl-induced signaling pathways in vivo. We propose that Jak1 is a mediator of v-Abl-induced STAT activation and v-Abl induced proliferation in BAF/3 cells, and may be important for efficient transformation of immature B cells by the v-abl oncogene.


* Corresponding author. Mailing address: Department of Medicine/Microbiology, Columbia University, 630 W. 168th St., New York, NY 10032-3702. Phone: (212) 305-6982. Fax: (212) 205-1870. E-mail: pbr3{at}columbia.edu.


Molecular and Cellular Biology, November 1998, p. 6795-6804, Vol. 18, No. 11
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Ning, S., Huye, L. E., Pagano, J. S. (2005). Regulation of the Transcriptional Activity of the IRF7 Promoter by a Pathway Independent of Interferon Signaling. J. Biol. Chem. 280: 12262-12270 [Abstract] [Full Text]  
  • Siavash, H., Nikitakis, N.G., Sauk, J.J. (2004). SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION: INSIGHTS INTO THE MOLECULAR BASIS OF ORAL CANCER. CROBM 15: 298-307 [Abstract] [Full Text]  
  • Gamero, A. M., Sakamoto, S., Montenegro, J., Larner, A. C. (2004). Identification of a Novel Conserved Motif in the STAT Family That Is Required for Tyrosine Phosphorylation. J. Biol. Chem. 279: 12379-12385 [Abstract] [Full Text]  
  • Kim, H., Xu, G.-L., Borczuk, A. C., Busch, S., Filmus, J., Capurro, M., Brody, J. S., Lange, J., D'Armiento, J. M., Rothman, P. B., Powell, C. A. (2003). The Heparan Sulfate Proteoglycan GPC3 Is a Potential Lung Tumor Suppressor. Am. J. Respir. Cell Mol. Bio. 29: 694-701 [Abstract] [Full Text]  
  • Ilangumaran, S., Finan, D., Raine, J., Rottapel, R. (2003). Suppressor of Cytokine Signaling 1 Regulates an Endogenous Inhibitor of a Mast Cell Protease. J. Biol. Chem. 278: 41871-41880 [Abstract] [Full Text]  
  • Sexl, V., Kovacic, B., Piekorz, R., Moriggl, R., Stoiber, D., Hoffmeyer, A., Liebminger, R., Kudlacek, O., Weisz, E., Rothammer, K., Ihle, J. N. (2003). Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation. Blood 101: 4937-4943 [Abstract] [Full Text]  
  • Warren, D., Griffin, D. S., Mainville, C., Rosenberg, N. (2003). The Extreme Carboxyl Terminus of v-Abl Is Required for Lymphoid Cell Transformation by Abelson Virus. J. Virol. 77: 4617-4625 [Abstract] [Full Text]  
  • Alas, S., Bonavida, B. (2003). Inhibition of Constitutive STAT3 Activity Sensitizes Resistant Non-Hodgkin's Lymphoma and Multiple Myeloma to Chemotherapeutic Drug-mediated Apoptosis. Clin. Cancer Res. 9: 316-326 [Abstract] [Full Text]  
  • Nakamura, Y., Grumont, R. J., Gerondakis, S. (2002). NF-{kappa}B1 Can Inhibit v-Abl-Induced Lymphoid Transformation by Functioning as a Negative Regulator of Cyclin D1 Expression. Mol. Cell. Biol. 22: 5563-5574 [Abstract] [Full Text]  
  • Oki, S., Limnander, A., Danial, N. N., Rothman, P. B. (2002). Functional involvement of Akt signaling downstream of Jak1 in v-Abl-induced activation of hematopoietic cells. Blood 100: 966-973 [Abstract] [Full Text]  
  • Chen, X. P., Losman, J. A., Cowan, S., Donahue, E., Fay, S., Vuong, B. Q., Nawijn, M. C., Capece, D., Cohan, V. L., Rothman, P. (2002). Pim serine/threonine kinases regulate the stability of Socs-1 protein. Proc. Natl. Acad. Sci. USA 99: 2175-2180 [Abstract] [Full Text]  
  • Fan, P.-D., Goff, S. P. (2000). Abl Interactor 1 Binds to Sos and Inhibits Epidermal Growth Factor- and v-Abl-Induced Activation of Extracellular Signal-Regulated Kinases. Mol. Cell. Biol. 20: 7591-7601 [Abstract] [Full Text]  
  • Warren, D., Heilpern, A. J., Berg, K., Rosenberg, N. (2000). The Carboxyl Terminus of v-Abl Protein Can Augment SH2 Domain Function. J. Virol. 74: 4495-4504 [Abstract] [Full Text]  
  • Zou, X., Cong, F., Coutts, M., Cattoretti, G., Goff, S. P., Calame, K. (2000). p53 Deficiency Increases Transformation by v-Abl and Rescues the Ability of a C-Terminally Truncated v-Abl Mutant To Induce Pre-B Lymphoma In Vivo. Mol. Cell. Biol. 20: 628-633 [Abstract] [Full Text]  
  • Humphreys, R. C., Hennighausen, L. (1999). Signal Transducer and Activator of Transcription 5a Influences Mammary Epithelial Cell Survival and Tumorigenesis. Cell Growth Differ. 10: 685-694 [Abstract] [Full Text]  
  • Zou, X., Calame, K. (1999). Signaling Pathways Activated by Oncogenic Forms of Abl Tyrosine Kinase. J. Biol. Chem. 274: 18141-18144 [Full Text]  
  • Nieborowska-Skorska, M., Wasik, M. A., Slupianek, A., Salomoni, P., Kitamura, T., Calabretta, B., Skorski, T. (1999). Signal Transducer and Activator of Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for Leukemogenesis. JEM 189: 1229-1242 [Abstract] [Full Text]  
  • Zhang, Y., Turkson, J., Carter-Su, C., Smithgall, T., Levitzki, A., Kraker, A., Krolewski, J. J., Medveczky, P., Jove, R. (2000). Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity. J. Biol. Chem. 275: 24935-24944 [Abstract] [Full Text]